- Home
- SKYE vs ALTG Comparison
SKYE vs ALTG Comparison
Compare SKYE & ALTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYE
- ALTG
- Stock Information
- Founded
- SKYE 2012
- ALTG 1984
- Country
- SKYE United States
- ALTG United States
- Employees
- SKYE N/A
- ALTG N/A
- Industry
- SKYE Biotechnology: Pharmaceutical Preparations
- ALTG Industrial Machinery/Components
- Sector
- SKYE Health Care
- ALTG Industrials
- Exchange
- SKYE Nasdaq
- ALTG Nasdaq
- Market Cap
- SKYE 115.9M
- ALTG 119.3M
- IPO Year
- SKYE N/A
- ALTG N/A
- Fundamental
- Price
- SKYE $3.98
- ALTG $7.98
- Analyst Decision
- SKYE Buy
- ALTG Buy
- Analyst Count
- SKYE 6
- ALTG 3
- Target Price
- SKYE $16.60
- ALTG $11.67
- AVG Volume (30 Days)
- SKYE 2.2M
- ALTG 338.7K
- Earning Date
- SKYE 08-08-2025
- ALTG 08-06-2025
- Dividend Yield
- SKYE N/A
- ALTG 2.78%
- EPS Growth
- SKYE N/A
- ALTG N/A
- EPS
- SKYE N/A
- ALTG N/A
- Revenue
- SKYE N/A
- ALTG $1,858,000,000.00
- Revenue This Year
- SKYE N/A
- ALTG $1.89
- Revenue Next Year
- SKYE N/A
- ALTG $3.09
- P/E Ratio
- SKYE N/A
- ALTG N/A
- Revenue Growth
- SKYE N/A
- ALTG N/A
- 52 Week Low
- SKYE $1.14
- ALTG $3.54
- 52 Week High
- SKYE $7.47
- ALTG $11.39
- Technical
- Relative Strength Index (RSI)
- SKYE 60.88
- ALTG 78.64
- Support Level
- SKYE $3.65
- ALTG $6.16
- Resistance Level
- SKYE $4.75
- ALTG $8.99
- Average True Range (ATR)
- SKYE 0.71
- ALTG 0.43
- MACD
- SKYE 0.00
- ALTG 0.21
- Stochastic Oscillator
- SKYE 48.55
- ALTG 85.30
About SKYE Skye Bioscience Inc. Common Stock
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
About ALTG Alta Equipment Group Inc.
Alta Equipment Group Inc is an integrated equipment dealership platform in the U.S. Its segments are Material Handling and Construction Equipment. The Material Handling segment is engaged in operations related to the sale, service, and rental of lift trucks in Michigan, Illinois, Indiana, New York, Virginia, and throughout the New England states whereas, the Construction Equipment segment is principally engaged in operations related to the sale, service, and rental of construction equipment in Michigan, Indiana, Illinois, Ohio, New York, Florida and throughout the New England States.